Company: LGN
Filing Date: 2025-05-14
Form Type: DRS/A
Source: 0000950123-25-005247
Chunk: 312

Company: Legence Corp.
Filing Date: 2025-05-14
Form: DRS/A
Chunk 312
---
-------:|:----|:--|-------:|
| Cash paid for interest and taxes                                                            |     |                         |        |     |   |        |     |   |        |
| Interest paid, net of interest rate swaps and interest capitalization (a)                   |     | $                       | 85,662 |     | $ | 61,794 |     | $ | 44,645 |
| Income taxes paid, net of refunds                                                           |     | $                       | 17,496 |     | $ | 10,160 |     | $ |    641 |
| Non-cash investing activities                                                               |     |                         |        |     |   |        |     |   |        |
| Property and equipment additions included in Accounts payable and Accrued and other current 
 liabilities                                                                                 |     | $                       |    429 |     | $ |    579 |     | $ |    439 |
| Non-cash financing activities                                                               |     |                         |        |     |   |        |     |   |        |
| Parent issuance of Parent interests for contingent consideration—related parties            |     | $                       |      — |     | $ |  9,325 |     | $ |  4,032 |
| Deferred offering costs included in Accounts payable                                        |     | $                       |  3,488 |     | $ |      — |     | $ |      — |

(a)The Company classifies the cash flows resulting from its interest rate swaps in Cash provided by operating activities on the Consolidated Statements of Cash Flows consistent with the interest that is hedged. See “ Note 11—Derivatives” for additional information on the Company’s interest rate swaps. See “ Note 4—Acquisitions” for disclosure of non-cashfinancing of acquisitions through issuance of Parent interests and promissory notes. F-58

Confidential Treatment Requested by Legence Corp.

Pursuant to 17 C.F.R. Section 200.83

Legence Holdings LLC and Subsidiaries

Notes to Consolidated Financial Statements

See “” for supplemental disclosures of
non-cash lease related information.

Note 20—Subsequent Events

The Company evaluated subsequent events through April 29, 2025, the date the Consolidated Financial Statements are available to be issued. Refer to
“” for subsequent term loan amendment.

F-59

Confidential Treatment Requested by Legence Corp.

Pursuant to